The "Cell Counting Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables & Accessories), by Application (Complete Blood Count, Stem Cell Research), by End-use, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global cell counting market size is expected to reach USD 15.46 billion by 2030, according to this report., expanding at a CAGR of 8.21% from 2022 to 2030. The rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer's is the high impact rendering growth driver of the industry. The increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.
An increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided a significant boost to the growth. The growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate the generation of accurate results are likely to improve the adoption of instruments over the coming years. For instance, in May 2021, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve the quality of preclinical studies.
Technological advancements in these devices are also broadening growth prospects of the market. One of the promising technological advancements in differential cell counting is the ability to recognize blasts, immunoplatelet counting, detection of blasts, and reticulocyte fractions and stem cell counting with greater accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful as an indicator of immune responses and has been adopted to evaluate the success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the FACSCount by Becton Dickinson is based on T-cell counting technology.
The COVID-19 pandemic is anticipated to positively impact the industry growth. WBC count of the COVID-19 patient during admission is significantly correlated with the death of patients. A higher level of white blood count should be given further care in the COVID-19 treatment. The growing importance of cell count in patients suffering from COVID-19 has augmented the growth of the industry during the pandemic.
The development of enhanced informatics solutions and improved image analysis instruments such as optical or fluorescence microscopes have fueled growth prospects of this market. These instruments are being increasingly adopted in low sample throughput laboratories and settings with limited resources, which is highly prevalent in developing economies, thereby broadening the scope for growth of the industry.
On the other hand, limited availability of skilled professionals is the critical growth-restraining factor of the market. The lack of skilled professionals can be attributed to lack of training facilities and high training costs. In order to improve this scenario, industry players are required to participate in the generation of training programs for software developed by these companies and encourage healthcare professionals and researchers to operate cell counting software. Moreover, lack of standardization of these software tools also plays a key role in restricting researchers and healthcare professionals as every software differs in user interface.
- Rising Prevalence of Chronic Diseases
- Increasing Government Funding for Cell Research
- Technological Advancements
- High Prices Associated With Advanced Cell Counting Systems
- Dearth of Skilled Professionals in Clinical Laboratories
- Applications of Cell Counting in Personalized Medicine
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Market Definitions
Chapter 3 Executive Summary
Chapter 4 Global Cell Counting Market Variables, Trends, & Scope
Chapter 5 Cell Counting Market - Segment Analysis, by product, 2018 - 2030 (USD Million)
Chapter 6 Cell Counting Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
Chapter 7 Cell Counting Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)
Chapter 8 Cell Counting Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
- Thermo Fisher Scientific, Inc.
- Merck Kgaa
- Agilent Technologies
- Perkinelmer, Inc.
- Bio-Rad Laboratories, Inc.
- Biotek Instruments, Inc.
- Ge Healthcare
- Denovix Inc.
For more information about this report visit https://www.researchandmarkets.com/r/7v0vpn
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900